Absci Corporation. was rising after a media report about the semiconductor company Advanced Micro Devices investing $20M in the AI drug creation company.
ABSI stock was trading +32% Wednesday pre-market at $4.05, while AMD was -2.8% to $123.76.
The private investment in public equity (PIPE) aims to help AMD increase the use of its AI chips in the healthcare sector, a January 8 report by the Wall Street Journal said.
The PIPE investment also includes an equity stake in Absci, according to the report.
The investment is reportedly Advanced Micro Devices' first attempt to enter the life sciences sector with its AI chips.
Absci is set to move toward greater use of AMD's GPUs, the report noted.
The biotechnology company is set to use the funds from the investment to continue building its AI models and to keep working on its internal drug development efforts, according to WSJ.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。